 |
 Official Journal of the Society of Radiopharmaceutical Sciences
Editor-in-Chief:
William C. Eckelman
See editorial board for all editors information
Description
Nuclear Medicine and Biology publishes original research covering all aspects of radiopharmaceutical chemistry: synthesis,
radiopharmacy, in vitro and ex vivo testing, and in vivo evaluation of molecular probes for PET, SPECT, planar imaging, and autoradiography.
These multidisciplinary studies demonstrate the mechanism of localization whether the radioactive substance is based on receptor, enzyme,
tumor antigen, or other well-defined biochemistry. The study should also address the sensitivity of the probe to changes in biochemistry,
although studies of mechanism alone are acceptable. Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate
provided that the specificity of labeled compound localization and therapeutic effect have been addressed. If the synthesis of a new
radiopharmaceutical is submitted alone, then the
uniqueness of the chemistry must be emphasized. Papers that describe instrumentation
important to molecular imaging as well as papers describing translational clinical research and the issues of extending preclinical research
to clinical studies are also welcome.
| Bibliographic details |
ISSN: 0969-8051
Imprint: ELSEVIER
Commenced publication 1973
Subscriptions for the year 2009,
Volume 36,
8 issues |
| Price and Ordering |
Institutional price:
USD 2,217
|
Personal price:
USD 492
|
Single issue price:
USD 99
|
Personal price USA:
USD 430
|
Institutional price USA:
USD 1,970
|
Conditions of sale & ordering procedures.
|
Audience
Scientists in nuclear medicine, biomedicine, pharmacology, and medicinal chemistry.
Impact factor of this journal
2007: 2.478
© Journal Citation Reports 2008, published by Thomson Reuters
To order this journal online, and for more information, go to http://www.elsevierhealth.com.
066/681
Last update: 9 Oct 2008
|
|
| |
